Pharmena S.A. (PHR.WA)
- Previous Close
4.3000 - Open
4.3100 - Bid 4.2800 x --
- Ask 4.3100 x --
- Day's Range
4.2800 - 4.3100 - 52 Week Range
3.5200 - 6.6800 - Volume
4,316 - Avg. Volume
2,505 - Market Cap (intraday)
48.339M - Beta (5Y Monthly) 1.17
- PE Ratio (TTM)
143.67 - EPS (TTM)
0.0300 - Earnings Date May 26, 2025 - May 30, 2025
- Forward Dividend & Yield 0.85 (19.54%)
- Ex-Dividend Date Apr 9, 2024
- 1y Target Est
--
Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including face, hair, and body care products, as well as dietary supplement. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland.
www.pharmena.euRecent News: PHR.WA
View MorePerformance Overview: PHR.WA
Trailing total returns as of 4/28/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PHR.WA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PHR.WA
View MoreValuation Measures
Market Cap
48.00M
Enterprise Value
37.36M
Trailing P/E
143.33
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.86
Price/Book (mrq)
4.08
Enterprise Value/Revenue
3.78
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-10.94%
Return on Equity (ttm)
-9.79%
Revenue (ttm)
308k
Net Income Avi to Common (ttm)
-1.68M
Diluted EPS (ttm)
0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
10.8M
Total Debt/Equity (mrq)
1.32%
Levered Free Cash Flow (ttm)
-2.28M